BeStock  
Stocks › Biotechnology › PBLS

Parabilis Medicines PBLS

US equityMarket cap rank #2333Biotechnology
$27.44 −$0.19 (-0.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $27.44 0.00%
Open$27.07
Prev close$27.63
Day range$26.50 – $28.52
Volume1.25M
Market cap$3.44B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership92.3%+3.99 pts vs. prior quarter
Institutions holding125+39 vs. prior quarter
Insider trades (recent)23 buys / 0 sellsNet buying
Short interest8.95% of floatDays to cover 8.3 · as of 30 Oct 2026
Short-sale volume share31.1%5-day average of daily volume

Short-sale volume as % of daily volume

15%24%32%41%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.16M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$3.6MSuper+$1.4MBig+$2.7MMid+$12.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 45.9% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.23.62%
  • FMR8.80%
  • Arch Venture Partners, L.P.5.19%
  • venBio LLC4.26%
  • Alphabet Inc.3.98%
  • GV Management Company, LLC3.98%
  • Nextech Invest Ltd.3.77%
  • Cormorant Asset Management, LP3.74%

By investor type

  • VC/PE Fund50.86%
  • Mutual Fund23.52%
  • Hedge Fund10.40%
  • Public Company7.47%
  • Individual/Insider0.10%
  • Government Pension Fund0.02%
  • Private Company0.00%
  • Family Office/Trust0.00%

Reported short interest has risen from 4.26% to 8.95% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +1,433,806 1.2%
BlackRock Mutual Fund 2026/Q3 +1,456,974 1.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +905,587 0.8%
State Street Global Advisors Mutual Fund 2026/Q3 +757,790 0.6%
FMR Mutual Fund 2026/Q3 +10,292,735 8.3%
Arch Venture Partners, L.P. VC/PE Fund 2026/Q3 +6,412,780 5.2%
venBio LLC VC/PE Fund 2026/Q3 +5,266,697 4.3%
GV Management Company, LLC VC/PE Fund 2026/Q3 +4,919,498 4.0%
Nextech Invest Ltd. VC/PE Fund 2026/Q3 +4,663,176 3.8%
Cormorant Asset Management, LP Hedge Fund 2026/Q3 +4,615,612 3.7%
Regeneron Pharmaceuticals, Inc. Public Company 2026/Q3 +4,166,666 3.4%
Artal Group S.A. VC/PE Fund 2026/Q3 +2,992,259 2.4%
Farallon Capital Management, L.L.C. Hedge Fund 2026/Q3 +2,368,200 1.9%
Janus Henderson Group plc Mutual Fund 2026/Q3 +2,296,547 1.9%
Frazier Life Sciences Management, LP VC/PE Fund 2026/Q3 +1,920,805 1.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
21 Aug 2026 Craig Tendler Independent Director Other Derivative Acquisition +20,294 $39.36 20,294
21 Aug 2026 Craig Tendler Independent Director Initial Statement of Beneficial +0 – 16,245
21 Jul 2026 RA Capital Management, L.P. Open Market Acquisition +244,593 $30.00 29,177,964
14 Jun 2026 Apothecary Capital LLC Open Market Acquisition +17,500 $27.67 30,000
10 Jun 2026 Edward Fitzgerald Independent Director Other Derivative Acquisition +3,666 – –
10 Jun 2026 Edward Fitzgerald Independent Director Other Derivative Acquisition +5,332 – –
10 Jun 2026 Edward Fitzgerald Independent Director Other Derivative Acquisition +8,111 – –
10 Jun 2026 Edward Fitzgerald Independent Director Derivative Exercise and Retained +14,688 – 14,688
10 Jun 2026 Alexis Borisy Independent Director Other Derivative Acquisition +162,221 – –
10 Jun 2026 Alexis Borisy Independent Director Derivative Exercise and Retained +105,414 – 105,414
10 Jun 2026 Deerfield Management Company, L.P. Derivative Exercise and Retained +1,880,704 – 1,880,704
10 Jun 2026 Apothecary Capital LLC Private Acquisition +12,500 $20.00 12,500
10 Jun 2026 RA Capital Management, L.P. Private Acquisition +21,188,750 $20.00 28,933,371
10 Jun 2026 RA Capital Management, L.P. Derivative Exercise and Retained +7,744,621 – 28,933,371
10 Jun 2026 Soleus Capital Management, L.P. Private Acquisition +500,000 $20.00 1,027,000
10 Jun 2026 Soleus Capital Management, L.P. Derivative Exercise and Retained +527,070 $9.48 1,027,000
8 Jun 2026 Edward Fitzgerald Independent Director Other Derivative Acquisition +20,215 $20.00 20,215
8 Jun 2026 Edward Fitzgerald Independent Director Initial Statement of Beneficial +0 – 64,980
8 Jun 2026 Alan Sebulsky Independent Director Other Derivative Acquisition +39,792 $20.00 39,792
8 Jun 2026 Alexis Borisy Independent Director Other Derivative Acquisition +20,215 $20.00 20,215

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 11,052,337 8.9% 8.3
15 Oct 2026 9,250,099 7.5% 9.5
30 Sep 2026 8,261,483 6.7% 4.8
15 Sep 2026 6,092,212 4.9% 13.3
31 Aug 2026 5,517,704 4.5% 14.2
14 Aug 2026 5,257,000 4.3% 15.7

Discussion

No comments yet — be the first to weigh in on PBLS.

Sign in to join the discussion.

Scroll to Top